R-Evolution Worldwide Community Interest Company

No-profit organization committed in the Research of Evolution and in the Evolution of Research for the achievement of the Global Sustainable Development Goals.

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

Last week we attended #WOHC🌍
We presented a poster on #MPOXPROBE (surveillance along Congo River against #Mpoxvirus), while A. Nyerere (SUA) presented on #NeuroSolve (Taenia solium prevention).
Both projects highlight the power of #OneHealth approach in global health research🔬

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

@Neuro_Solve

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

Visiting the @ifakarahealth Institute during the @neurosolve project Annual Meeting in Morogoro 🇹🇿

IHI is a key actor in advancing research on #neurocysticercosis & #epilepsy in Tanzania and Zambia, where our project in ongoing.

Global health partnerships in action! 🌍

[INTEGRATION IPTp-SP @INTEGRATIONiptp]

To find out more about this topic, click on the following link: https://t.co/1qu3PtljMZ

[INTEGRATION IPTp-SP @INTEGRATIONiptp]

20th August 2024: World Moquito Day

[INTEGRATION IPTp-SP @INTEGRATIONiptp]

Click here for more information about this new publication from INTEGRATION team: https://t.co/AS0tdtyvYo

[INTEGRATION IPTp-SP @INTEGRATIONiptp]

To know more about this topic, click the following link: https://t.co/1qu3PtljMZ

[NeuroSolve @Neuro_Solve]

The NeuroSolve Project members of the CENTD (Consortium of Experts in Neglected Tropical Diseases) network were invited to be part of the meetings and to give a presentation on the implementation research activities of the project. To know more: https://t.co/8BFsFWEZGB

[NeuroSolve @Neuro_Solve]

Part 2 of #NeuroSolvePills series!

Did you know that?
The total number of people with neurocysticercosis in sub-Saharan Africa was estimated to be 2.56–8.30 million.
To know more about this and about NeuroSolve project click here: https://t.co/bI6tHnANcv

[NeuroSolve @Neuro_Solve]

A workshop on Statistics and Data Management applied to Clinical Research has been conducted for NeuroSolve’s PhDs and Masters students. This was the third capacity building activity implemented as per the NeuroSolve project plan.
Click here to read more:
https://t.co/RrMi9sCFK7

[NeuroSolve @Neuro_Solve]

NeuroSolve obtained the Clinical Trial Ethical Approval in Zambia!
After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis in Zambia.

[NeuroSolve @Neuro_Solve]

NeuroSolve project supports the #WorldPatientSafetyDay !
NeuroSolve aims to improve tools for diagnosis and (thereby) access to NCC specific treatment, providing a blueprint for meaningful implementation research and demonstrate how research can strengthen healthcare systems.

[NeuroSolve @Neuro_Solve]

It is important to prevent neurocysticercosis:
•Do not eat infected pork meat
•Eat well cooked pork meat
•Wash your hands often
•Keep pigs in pens

We talked with Prof. Evans Mwape, NeuroSolve's PI for Zambia. To know more: https://t.co/0Qu75biMqr

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

African and European multidiscplinary researchers established an integrated consortium to develop a research project on the dengue and Zika viruses affecting Africa and the world

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

A multidisciplinary consortium of African and European researchers was able to respond to the urgent call from the European Union by developing a research project on the Monkeypox outbreak in central Africa.

[NeuroSolve @Neuro_Solve]

A course about GCPs and GCLPs was offered in Tanzania by NeuroSolve facilitators from NIMR and @UdsmOfficial . Participants included Principal Investigators, Co-Principal Investigator, technical personnel and PhD students in Tanzania. #neurosolve #neurocysticercosis #ntds

[NeuroSolve @Neuro_Solve]

NeuroSolve's PhD and Masters students joined a short training course entitled "Implementation Science in One Health: Bridging the gap between research and 'real world' ". The topics were treated through a theoretical-practical approach, followed by the analysis of a case study.

[NeuroSolve @Neuro_Solve]

NeuroSolve's Clinical Trial has been successfully registered on PACTR. This important achievement is only the beginning of our fight against Neurocysticercosis, a major cause of acquired epilepsy in middle-and-low-income countries. NeuroSolve is a project funded by EDCTP3.

[NeuroSolve @Neuro_Solve]

A NeuroSolve poster was presented at the European Congress on Tropical Medicine and International Health 2023. NeuroSolve is research aiming to implement a superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa.

[NeuroSolve @Neuro_Solve]

The #NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka, hosted by the University of Zambia #UNZA. This research aims to implement a superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa.